Epidemiology and clinical features of intraocular lymphoma

Ocular Immunology and Inflammation

Volumn 17, Issue 2, 2009, Pages 69-72

  Mochizuki, Manabu ^a   Singh, Arun D ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CLINICAL FEATURE; ETHNICITY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTRAOCULAR TUMOR; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; REVIEW; RISK FACTOR;

CENTRAL NERVOUS SYSTEM NEOPLASMS; EYE DISEASES; EYE NEOPLASMS; HUMANS; INCIDENCE; LYMPHOMA; RISK FACTORS; VISION DISORDERS;

EID: 67651241528     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940902957305     Document Type: Review

References (30)

1. Chan CC, Gonzales JA, Hidayat AA. Intraocular lymphopro-liferations simulating uveitis. In: Albert DM, Miller JW, eds. Principles and Practice of Ophthalmology, 3 ed. New York: Saunders-Elsevier, 2008.
2. Singh AD, Lewis H, Schachat AP, Peereboom D. Lymphoma of the retina and CNS. In: Singh AD, Damato BE, Péer J, et al., eds. Clinical Ophthalmic Oncology. Philadelphia: Saunders-Elsevier, 2007.
3. Bardenstein DS. Intraocular Lymphoma. Cancer Control 1998;5:317-25.
4. Schabet M. Epidemiology of primary CNS lymphoma. J Neu-rooncol. 1999;43:199-201.
5. Chan CC. Molecular pathology of primary intraocular lym-phoma. Trans Am Ophthalmol Soc. 2003;101:275-92.
6. Corn BW, Marcus SM, Topham A, et al. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997;79:2409-13.
7. Kadan-Lottick NS, Skluzacek MC, Gurney JG. Decreasing incidence rates of primary central nervous system lymphoma. Cancer 2002;95:193-202.
8. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003;361:323-31.
9. Cote TR, Manns A, Hardy CR, et al. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst. 1996;88:675-9.
10. Deangelis LM, Hormigo A. Treatment of primary central nervous system lymphoma. Semin Oncol. 2004;31:684-92.
11. Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer 1993;72: 843-9.
12. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999;106:1805-10.
13. Rockwood EJ, Zakov ZN, Bay JW. Combined malignant lym-phoma of the eye and CNS (reticulum-cell sarcoma). Report of three cases. J Neurosurg. 1984;61:369-74.
14. Goto H, Mochizuki M, Yamaki K, et al. Epidemiological survey of intraocular inflammation in Japan. Jpn J Ophthalmol. 2007;51:41-4.
15. WenderA,AdarA, MaorE, YassurY.Primary B-cell lymphoma of the eyes and brain in a 3-year-old boy. Arch Ophthalmol 1994;112:450-1.
16. Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000;8:243-50.
17. Sugita S, Takase H, Sugamoto Y, et al. Diagnosis of intraocular lymphoma with a combination of polymerase chain reaction and cytokine profile in the vitreous fluids. Jpn J Ophthalmol. 2009; In press.
18. Surawicz TS, McCarthy BJ, Kupelian V, et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol. 1999;1:14-25.
19. Freeman LN, Schachat AP, Knox DL, et al. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987;94:1631-9.
20. Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 1988;95:625-30.
21. Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lym-phoma. Clinical and histopathologic diagnosis. Ophthalmology 1993;100:1399-406.
22. Ridley ME, McDonald HR, Sternberg P, Jr., et al. Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology 1992;99:1153-60; discussion 60-1.
23. Corriveau C, Easterbrook M, Payne D. Lymphoma simulating uveitis (masquerade syndrome). Can J Ophthalmol. 1986;21:144-9.
24. Dean JM, Novak MA, Chan CC, Green WR. Tumor detachments of the retinal pigment epithelium in ocular/ central nervous system lymphoma. Retina 1996;16:47-56.
25. Gass JD, Sever RJ, Grizzard WS, et al. Multifocal pigment epithelial detachments by reticulum cell sarcoma. A characteristic funduscopic picture. Retina 1984;4:135-43.
26. Fredrick DR, Char DH, Ljung BM, Brinton DA. Solitary intraocular lymphoma as an initial presentation of widespread disease. Arch Ophthalmol. 1989;107:395-7.
27. Gass JD, Trattler HL. Retinal artery obstruction and atheromas associated with non-Hodgkin's large cell lymphoma (reticulum cell sarcoma). Arch Ophthalmol. 1991;109:1134-9.
28. Michelson JB, Michelson PE, Bordin GM, Chisari FV. Ocular reticulum cell sarcoma. Presentation as retinal detachment with demonstration of monoclonal immunoglobulin light chains on the vitreous cells. Arch Ophthalmol. 1981;99:1409-11.
29. Hautzer NW, Aiyesimoju A, Robitaille Y. "Primary" spinal intramedullary lymphomas: a review. Ann Neurol. 1983;14: 62-6.
30. Balmaceda C, Gaynor JJ, Sun M, et al. Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications. Ann Neurol. 1995;38: 202-9.